Abstract
A phase 1/2 double-blind, placebo-controlled study of SAGE-217 in a phase advance model of transient insomnia
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have